RD

Rupak Dhar

Active Director Designated Partner DIN 11439925
DIN 11439925 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rupak Dhar

Data last updated:

Rupak Dhar is a Designated Partner at Curezen Lifesciences Llp (since 2025). The company operates in Pharma.

DIN 11439925
Primary Designation Designated Partner
Industry Pharma
First Appointment 19 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Dec 20252025Active

Board colleagues of Rupak Dhar

NameDINCompanyDesignation
Pankaj Mazumdar11439927Curezen Lifesciences LlpDesignated Partner
Sarika Dhar11439928Curezen Lifesciences LlpDesignated Partner
Subrata Kumar Saha11439926Curezen Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curezen Lifesciences Llp
Premium access

Shareholding and investment profile for Rupak Dhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupak Dhar

Rupak Dhar currently holds 1 directorship: Curezen Lifesciences Llp (Designated Partner, since 19 Dec 2025).

Rupak Dhar was first appointed on 19 Dec 2025 as Designated Partner at Curezen Lifesciences Llp.

The current boards of Rupak Dhar's companies include Pankaj Mazumdar (Curezen Lifesciences Llp), Sarika Dhar (Curezen Lifesciences Llp), Subrata Kumar Saha (Curezen Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available